Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Marvel Biosciences Corp (MRVL.VN)

Marvel Biosciences Corp (MRVL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,473
  • Shares Outstanding, K 52,954
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,650 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 06/17/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.135 +18.52%
on 12/04/25
0.205 -21.95%
on 11/06/25
-0.045 (-21.95%)
since 11/05/25
3-Month
0.135 +18.52%
on 12/04/25
0.275 -41.82%
on 09/08/25
-0.110 (-40.74%)
since 09/05/25
52-Week
0.075 +113.33%
on 05/26/25
0.400 -60.00%
on 08/29/25
+0.010 (+6.67%)
since 12/05/24

Most Recent Stories

More News
Marvel Biosciences Announces Grant of Deferred Share Units

Calgary, Alberta--(Newsfile Corp. - November 10, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Acceleration of Warrant Expiry Date

Calgary, Alberta--(Newsfile Corp. - October 3, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is announcing...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204

Calgary, Alberta--(Newsfile Corp. - August 18, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"),...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Grant of Deferred Share Units

Calgary, Alberta--(Newsfile Corp. - August 11, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Closing of Private Placement

Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Closing of Second Tranche of Private Placement

Calgary, Alberta--(Newsfile Corp. - May 2, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Announces the Second of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide Following Cessation of Drug Treatment

Calgary, Alberta--(Newsfile Corp. - April 30, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences to Give Oral Presentation at The Annual IRSF Rett Syndrome Scientific Meeting

Calgary, Alberta--(Newsfile Corp. - April 16, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (together "Marvel"), are pleased to...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Selected to Present Alzheimer's Research at the 2025 Alzheimer's Association International Conference

Calgary, Alberta--(Newsfile Corp. - April 14, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"),...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)
Marvel Biosciences Announces Private Placement

Calgary, Alberta--(Newsfile Corp. - March 28, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.160 (unch)
MBCOF : 0.1121 (-1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with...

See More

Key Turning Points

3rd Resistance Point 0.182
2nd Resistance Point 0.173
1st Resistance Point 0.167
Last Price 0.160
1st Support Level 0.152
2nd Support Level 0.143
3rd Support Level 0.137

See More

52-Week High 0.400
Fibonacci 61.8% 0.276
Fibonacci 50% 0.238
Fibonacci 38.2% 0.199
Last Price 0.160
52-Week Low 0.075

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar